PAEDIATRIC ONCOLOGY - HOME BLOOD COUNT PROCEDURE 1. Aim/Purpose of this Guideline

Similar documents
CLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline

2.1. Applicable areas: Royal Cornwall Hospitals Trust; Neonatal Unit and Delivery Suite

ESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline

Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline

Loading Dose Worksheet for Oral Amiodarone

CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline

School Vision Screening Policy V2.0

CLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start

CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline

MANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS)

Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0

Policy on Governance Arrangements Relating to Medicines V2.0

Diagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging

A list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department.

CLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0

CLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE

PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0

Diagnostic Testing Procedures in Urodynamics V3.0

CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR: Management of low-risk upper GI haemorrhage. Page 1 of 10. Management of low-risk upper GI haemorrhage

OXYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0

1.3 Referrer: in the context of this protocol the term referrer refers to a health care worker who is authorised to refer individuals for X-rays.

Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary.

IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist within RCHT. 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS

CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline

Safe Bathing Policy V1.3

This guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin.

Newborn Hearing Screening Programme Policy

2.1. It is essential that promoting and safeguarding the welfare of children and young people is integral to all NHS Trust policies and procedures.

WARD CLOSURE POLICY V

The initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0

Diagnostic Testing Procedures in Neurophysiology V1.0

Tissue Viability Referral Pathway. April 2017

Safeguarding Children Supervision Policy V4.0. November 2016

Diagnostic Testing Procedures for Ophthalmic Science

Procedure for the Application of a Cast and its subsequent care V1.3

2.2. Preoperative preparation: Ensure that the child/young person is fit for surgery. If there is any doubt consult the anaesthetist.

CLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND

CEREBRAL FUNCTION MONITORING (aeeg). NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR MAXIMUM SURGICAL BLOOD ORDER SCHEDULE (MSBOS) Summary.

Patient Experience Strategy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy

Occupational Health Surveillance Policy V2.1

Health and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Named Key Worker for Cancer Patients Policy

Severe Weather Plan V5.5 March 2018

Early detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Patients Wills Policy

RCHT Non-Ionising Radiation Safety Policy

CLINICAL GUIDELINE FOR TRANSFERS AND DISCHARGES IN THE LAST FEW WEEKS OF LIFE 1. Aim/Purpose of this Guideline

PHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives

CLINICAL GUIDELINE FOR Management of NON-VARICEAL Upper GI haemorrhage

Services. This policy should be read in conjunction with the following statement:

Safe Staffing Levels for. Midwifery, Nursing and Support Staff. For Maternity Service - Approved. Document V1.5. June 2017

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Code of Practice for Wound Care Company Representatives and Staff with whom they interact

POLICY ON THE HANDLING OF CHEMOTHERAPY BY STAFF WHO ARE PREGNANT OR BREASTFEEDING

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Strong Potassium Solutions Safe Handling and Storage

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines

Hand Hygiene Policy V2.1

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Patient Choice Directive Policy & Guidance

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Procedure for Monitoring of Delayed Transfers of Care

Ref No: 2135 Title: Liquidised food through enteral feeding tubes in the community (Paediatric SOP) Version No: 1. Date of Issue: 10 March 2017

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures

It is essential that patients are aware of, and in agreement with, their referral to palliative care.

The Newcastle upon Tyne NHS Hospitals Foundation Trust. Latex Operational Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust

Person/persons conducting this assessment with Contact Details Marilyn Rees Lead VTE Nurse ext 48729

Executive Director of Nursing and Chief Operating Officer

Medicines Reconciliation Policy

Document Title: Training Records. Document Number: SOP 004

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients

Provision of Wigs Policy

NHS Greater Glasgow and Clyde Equality Impact Assessment Tool For Strategy, Policy and Plans

ORAL ANTI-CANCER THERAPY POLICY

CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Employment Policies and Procedures. Breastfeeding Supporting Staff Policy

Access to Health Records Procedure

Exchange Transfusion Neonatal Clinical Guideline V1.0 February 2018

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Use of Patients Own Drugs (PODs)

STANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES

Drainage of Abdominal Ascites

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Injectable Medicines Policy

Plan For VIPs and Protected Persons

Hepatitis B Immunisation procedure SOP

STANDARD OPERATING PROCEDURE THE TRANSPORTATION OF PRESCRIBED CONTROLLED DRUGS AND OTHER URGENTLY REQUIRED MEDICATION BY COMMUNITY NURSES

Freedom to speak up: raising concerns (whistleblowing) policy

Learning from Deaths Policy LISTEN LEARN ACT TO IMPROVE

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Key Control Operational Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Protected Mealtime Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Animals on Hospital Premises Policy

Positive and Safe Management of Post incident Support and Debrief. Ron Weddle Deputy Director, Positive and Safe Care

Animals and Pets in Healthcare Facilities Policy

Policy for Failure to Bring/Attend Children s Health Appointments Whittington Health 2012/2013

Central Alerting System (CAS) Policy

Equal Pay Statement and Gender Pay Gap Information

Transcription:

PAEDIATRIC ONCOLOGY - HOME BLOOD COUNT PROCEDURE 1. Aim/Purpose of this Guideline 1.1. This guideline applies to CLIC Sargent and Paediatric Oncology outreach Nurses performing blood counts in a patient s home. 2. The Guidance 2.1. When home count blood tests have been performed by the CLIC Sargent and Paediatric Outreach Nurses, they will: Ensure patient name / home count blood test is recorded in the CLIC diary Retrieve the blood test results and discuss them with the authorised Paediatric Oncology Team clinicians. They will advise about necessary changes to therapy. The parent / carer is then telephoned by a member of the Paediatric Oncology Team and informed of the results and any changes to therapy. The results and plan for continuing treatment is recorded in the child s hospital notes. This must be completed on the day of the blood test and results. If on any occasion these doctors are unavailable, the results should be discussed with the middle grade doctor covering for oncology or authorised Chemotherapy competent Non-Medical Prescriber(s), who should interpret them in conjunction with the guidelines for dose adjustments. Oncology protocols are held in CLIC office on the CLIC Unit. If there is any doubt, further advice should be sought from the appropriate on-call Paediatric Haematologist/Oncologist or a member of their team at Bristol Royal Hospital for Children. If home count results have implications for in-patient treatment, this will be discussed and planned with Ward staff. Home count blood test arrangements will be planned in advance at the weekly MDT and /or after the weekly Paediatric Oncology Clinic. Page 1 of 7

3. Monitoring compliance and effectiveness Element to be monitored Lead Tool Frequency Reporting arrangements Acting on recommendations and Lead(s) Change in practice and lessons to be shared All elements of procedure. Oncology multi-disciplinary team. Audit and peer review process. Annually Oncology multi-disciplinary team. Directorate audit and guidelines Oncology multi-disciplinary team. Directorate audit and guidelines Required changes to practice will be identified and actioned within 6-12 months. A lead member of the team will be identified to take each change forward where appropriate. Lessons will be shared with all the relevant stakeholders 4. Equality and Diversity 4.1. This document complies with the Royal Cornwall Hospitals NHS Trust service Equality and Diversity statement which can be found in the 'Equality, Diversity & Human Rights Policy' or the Equality and Diversity website. 4.2. Equality Impact Assessment The Initial Equality Impact Assessment Screening Form is at Appendi 2. Page 2 of 7

Appendi 1. Governance Information Document Title Date Issued/Approved: July 2017 Paediatric Oncology- Home Blood Count Procedure Date Valid From: July 2017 Date Valid To: July 2020 Directorate / Department responsible (author/owner): Paediatric Oncology Team Contact details: 01872 252891 Brief summary of contents Process for CLIC nurses carrying out Home blood counts on oncology patients. Suggested Keywords: Target Audience Eecutive Director responsible for Policy: Date revised: July 2017 This document replaces (eact title of previous version): Approval route (names of committees)/consultation: Oncology Paediatric Child Blood count Home blood test RCHT PCH CFT KCCG Eecutive Director Paediatric Oncology- Home Blood Count Procedure 2014 Paediatric oncology MDT Directorate business and guidelines meeting Divisional Manager confirming approval processes Name and Post Title of additional signatories Name and Signature of Divisional/Directorate Governance Lead confirming approval by specialty and divisional management meetings David Smith Not Required {Original Copy Signed} Name: Helen Ross-Magill Signature of Eecutive Director giving approval {Original Copy Signed} Page 3 of 7

Publication Location (refer to Policy on Policies Approvals and Ratification): Document Library Folder/Sub Folder Links to key eternal standards Related Documents: Training Need Identified? Internet & Intranet Paediatrics none none none Intranet Only Version Control Table Date Version No Summary of Changes Changes Made by (Name and Job Title) April 12 V1.0 Initial Issue. June 14 V2.0 Content review and re format. Dr.K.Macdonald Sabrina Tierney Dr.K.Macdonald Sabrina Tierney June 17 V3.0 Content review minor changes to job titles, re format. Karen Berriman CLIC Sargent Paediatric Oncology Outreach Nurse Specialist, All or part of this document can be released under the Freedom of Information Act 2000 This document is to be retained for 10 years from the date of epiry. This document is only valid on the day of printing Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy on Document Production. It should not be altered in any way without the epress permission of the author or their Line Manager. Page 4 of 7

Appendi 2. Initial Equality Impact Assessment Form This assessment will need to be completed in stages to allow for adequate consultation with the relevant groups. Name of the strategy / policy /proposal / service function to be assessed Paediatric Oncology- Home blood count procedure. Directorate and service area: child health Is this a new or eisting Policy?eisting Name of individual completing assessment: K.Berriman 1. Policy Aim* Who is the strategy / policy / proposal / service function aimed at? Telephone: 01872252069 Set guidance for CLIC nurses performing home blood counts on paediatric oncology patients. 2. Policy Objectives* Set guidance for CLIC nurses performing home blood counts on paediatric oncology patients. 3. Policy intended Standardised practice Outcomes* 4. *How will you measure the outcome? 5. Who is intended to benefit from the policy? 6a Who did you consult with b). Please identify the groups who have been consulted about this procedure. What was the outcome of the consultation? Audit and review Children and families Workforce Patients Local groups Please record specific names of groups Oncology MDT Paediatric business meeting. Procedure agreed. Eternal organisations Other Page 5 of 7

7. The Impact Please complete the following table. If you are unsure/don t know if there is a negative impact you need to repeat the consultation step. Are there concerns that the policy could have differential impact on: Equality Strands: Yes No Unsure Rationale for Assessment / Eisting Evidence Age Se (male, female, trans-gender / gender reassignment) Race / Ethnic communities /groups Disability - Learning disability, physical impairment, sensory impairment, mental health conditions and some long term health conditions. Religion / other beliefs Marriage and Civil partnership Pregnancy and maternity Seual Orientation, Biseual, Gay, heteroseual, Lesbian You will need to continue to a full Equality Impact Assessment if the following have been highlighted: You have ticked Yes in any column above and No consultation or evidence of there being consultation- this ecludes any policies which have been identified as not requiring consultation. or Major this relates to service redesign or development 8. Please indicate if a full equality analysis is recommended. Yes No 9. If you are not recommending a Full Impact assessment please eplain why. No areas indicated. Page 6 of 7

Signature of policy developer / lead manager / director K.Berriman Date of completion and submission July 2017 Names and signatures of members carrying out the Screening Assessment 1. 2. Human Rights, Equality & Inclusion Lead Keep one copy and send a copy to the Human Rights, Equality and Inclusion Lead c/o Royal Cornwall Hospitals NHS Trust, Human Resources Department, Knowledge Spa, Truro, Cornwall, TR1 3HD This EIA will not be uploaded to the Trust website without the signature of the Human Rights, Equality & Inclusion Lead. A summary of the results will be published on the Trust s web site. Signed K.Berriman Date July 2017 Page 7 of 7